Neurovive Pharmaceutical AB News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.03.15	NeuroVive Pharmaceutical AB (publ) - Amendment Number of Shares and Votes (Businesswire)
30.03.15	NeuroVive Pharmaceutical AB (publ): report from AGM (Businesswire)
18.03.15	Neurovive Pharmaceutical: NeuroVive Pharmaceutical publishes English version of annual report for 2014 (Businesswire)
25.02.15	Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ) (Businesswire)
20.02.15	NeuroVive Completes a Directed Share Issue of SEK 65 Million for Continued Expansion (Businesswire)
18.02.15	NeuroVive: Year-End Report 1 Jan. 2014 till 31 Dec. 2014 (Businesswire)
11.02.15	Neurovive Pharmaceutical: New Subsidiary Secures Funding of Just over USD 3 m Ahead of Potential IPO in Taiwan (Businesswire)
05.02.15	OnCore Biopharma and Tekmira Pharmaceuticals Files for Merger – Releases Further Details about License Agreement With NeuroVive (Businesswire)
19.01.15	Neurovive Pharmaceutical: Merger Between Oncore and Tekmira Includes Development of NVP018 for the Treatment of Hepatitis B (Businesswire)
12.01.15	Neurovive Pharmaceutical: Annual General Meeting Brought Forward to March 30 2015 (Businesswire)
08.12.14	NeuroVive Pharmaceutical: NeuroVive Employs a Clinical Trial Manager (Businesswire)
02.12.14	Neurovive Pharmaceutical: NeuroVive and Skåne University Hospital Initiate Collaboration on Clinical Phase II Study on Kidney Protection During Heart Surgery (Businesswire)
19.11.14	NeuroVive: Interim Report 1 Jan. 2014 to 30 Sep. 2014 (Businesswire)
29.10.14	Neurovive Pharmaceutical: Annual General Meeting 2015 and Information about Members Appointed to the Nomination Committee (Businesswire)
11.09.14	Neurovive Pharmaceutical: Addendum: OnCore License (Businesswire)
09.09.14	Neurovive Pharmaceutical: NeuroVive signs USD 150 m agreement with OnCore BioPharma for the outlicensing of NVP018 for the treatment of chronic Hepatitis B virus infection (Businesswire)
20.08.14	Neurovive Pharmaceutical: NeuroVive: Interim Report 1 Jan. 2014 to 30 Jun. 2014 (Businesswire)
15.08.14	Neurovive Pharmaceutical: Enrollment To Phase II Study On NeuroSTAT® Continues (Businesswire)
10.06.14	Neurovive Pharmaceutical: NeuroVive’s Research into Energy Regulation Wins Award at International Research Symposium (Businesswire)
04.06.14	Neurovive Pharmaceutical: NeuroVive signs new agreement with Hospices Civils de Lyon (Businesswire)
09.05.14	Neurovive Pharmaceutical: Report From AGM (Businesswire)
09.05.14	Neurovive: Interim Report 1 Jan. 2014 Till 31 Mar. 2014 (Businesswire)
17.04.14	Neurovive Pharmaceutical: NeuroVive Presents Medical Breakthrough in Cellular Energy Regulation (Businesswire)
10.04.14	Invitation to the AGM of NeuroVive Pharmaceutical AB (publ) (Businesswire)
10.04.14	Neurovive Pharmaceutical: NeuroVive Stock Now Trading in the USA on the OTC Market (Businesswire)
31.03.14	Neurovive Pharmaceutical: Increased Individual Ownership Through Share Exchange from Maas Biolab, LLC (Businesswire)
28.03.14	Neurovive Pharmaceutical: NeuroVive presents significant hepatitis B data for its drug candidate NVP018 (Businesswire)
25.03.14	NeuroVive Pharmaceutical and A1M Pharma initiate research collaboration (Businesswire)
10.03.14	NeuroVive Pharmaceutical: NeuroVive starts collaboration to evaluate IPO of subsidiary in Taiwan (Businesswire)
19.02.14	Neurovive Pharmaceutical: NeuroVive: Year-End Report 1 Jan. 2013 Till 31 Dec. 2013 (Businesswire)
17.02.14	Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion® (Businesswire)
31.01.14	Neurovive Pharmaceutical: NeuroVive rights issue 270% oversubscribed (Businesswire)
29.01.14	NeuroVive Pharmaceutical: NeuroVive Extends Partnership Agreement with inVentiv Health to Prepare for Upcoming Market Launch (Businesswire)
23.01.14	Neurovive Pharmaceutical: Supplementary Subscription Undertakings by Transfer of Subscription Rights (Businesswire)
15.01.14	Neurovive Pharmaceutical: Senior managers’ and Directors’ subscriptions in new issue (Businesswire)
08.01.14	NeuroVive Pharmaceutical AB (publ) publishes prospectus (Businesswire)
18.12.13	NeuroVive—SEK 35 m private placement complete, more information on forthcoming SEK 75.8 m rights issue (Businesswire)
13.12.13	Neurovive Pharmaceutical: Report from Extraordinary General Meeting (Businesswire)
22.11.13	Correction: NeuroVive Proposes Resolution on Private Placement and Rights Issue Totaling Approximately SEK 111 M (Businesswire)
21.11.13	Neurovive Pharmaceutical: NeuroVive: Interim Report 1 Jan. 2013 till 30 Sep. 2013 (Businesswire)
20.11.13	Neurovive Pharmaceutical: NeuroVive Proposes Resolution on Private Placement and Rights Issue Totaling Approximately SEK 111 m (Businesswire)
09.10.13	NeuroVive Pharmaceutical: Catharina Johansson Appointed New CFO, Effective 1 December (Businesswire)
27.08.13	NeuroVive: Interim Report 1 Jan. 2013 till 30 Jun. 2013 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu Neurovive Pharmaceutical AB

Aktien Top/Flop

Meistgelesene Nachrichten